public health (4).edited (1).edited(1)

The risk of antibiotic resistance should not prevent prophylactic antibiotic use where the likelihood of preventable infections is high.

Introduction The widespread use of antibiotics has been one of the most significant advances in modern medicine, but antibiotic resistance poses a serious threat to their effectiveness (Fernandez et al., 2019). This essay investigates the moral implications of using antibiotics for prevention in high-threat situations. Antibiotic prophylaxis is an attractive strategy in which healthy people are given antibiotics to reduce their chance of illness. Even though antibiotic resistance is a growing problem, this essay argues that there are circumstances where the benefits of preventive antibiotics exceed the hazards. A crucial problem for public health decision-makers is balancing the requirement to prevent infections with the need to safeguard antibiotic efficacy (Deng et al., 2008). Argument And Position The benefits of preventing infections, according to proponents of prophylactic antibiotic use, exceed the possible hazards of fostering antibiotic resistance. They emphasized the following points: 1. Effectiveness in High-Risk Settings: Research has demonstrated that the use of prophylactic antibiotics can effectively prevent infections in high-risk settings, including surgery, patients experiencing neutropenia, and people with prosthetic heart valves (Durack et al., 2017; Mangram et al., 2013; Aktas et al., 2010). 2. Huge Benefits: Both individual health and public health can greatly benefit from infection prevention. Serious consequences, extended hospital stays, and even death are all possible outcomes of infections. Additionally, preventing infections can lower medical expenses and raise the general quality of life.

development. Antibiotic resistance is a severe problem in medicine. Outbreaks of healthcare-related infections caused by resistant viruses are a common problem in hospitals and nursing homes. According to the Centers for Disease Control and Prevention (CDC) (CDC, 2019), more than 35,000 people die from infectious diseases per year (Harland, 2020). Benefits and Risks of Prophylactic Antibiotic Prophylactic antibiotics should be used when the danger of infection is high, such as before surgery or in immunocompromised patients (Ariza-Heredia & Chemaly, 2018). Antibiotic prophylaxis is an important preventative measure for those with weakened immune systems. However, there are potential side effects associated with preventive antibiotic use. Due to the practice of giving antibiotics to healthy people, it can promote antibiotic resistance (Willis & Chandler, 2019). Ethical questions arise when considering the trade-offs between short- term advantages in public health from preventing infections and longer-term losses. Ethical Frameworks in Public Health Ethical decision-making in public health is a multidimensional process that draws from numerous philosophical frameworks and concepts (Kasirzadeh, 2023). Different ethical theories and principles might help analyze public health issues and make policy decisions (Brock, 2018). In this essay, we will examine many of the most prominent ethical theories utilized in public health ethics today: Utilitarianism:

According to utilitarianism, the proper course of action is the one that results in the most significant amount of aggregate happiness or utility (Abumere, 2019). Utilitarianism is frequently used to evaluate the best outcome for the most significant number of people in public health. Interventions are evaluated based on their potential benefits and risks to the population (Ikechukwu et al., 2022). For this reason, utilitarians might measure the advantages of avoiding infections when using preventive antibiotics against the risks of developing antibiotic resistance in high-risk scenarios. Deontology: Contrary to utilitarianism, deontological ethics emphasizes actions' inherent rightness or wrongness, independent of their consequences (Singh & Mishra, 2018). Deontologically informed public health professionals may prioritize ethical obligations, including protecting patients' rights and honouring patients' choices (Whitney, 2020). Even if the goal is to prevent illnesses, a deontologist may argue that exposing patients to the risks of antibiotic resistance through prophylactic antibiotics is unethical. Virtue Ethics: Virtue ethics focuses on moral agents and their deeds (018). Compassion, honesty, and wisdom are just a few of the virtues that virtue ethicists hope to instil in themselves and others (Jackson, 2018). This method may require the development of character strengths that underpin sound ethical judgment, such as the ability to weigh the welfare of patients against the need for irresponsible antibiotic usage. Principlism:

3. Organizations' policies: Hospitals and other healthcare providers typically develop antibiotic policies and recommendations independently (Kakkar et al., 2020). While these codes may differ, they are generally consistent with national and international standards. Institutional guidelines for the consistent and ethical use of antibiotics should accompany clinical practice. Ethical Frameworks and Principles Ethical considerations and policies play an essential role in public health decisions about antibiotic resistance and the use of prophylactic antibiotics. Ethical considerations in public health decision-making generally include the following: Non-Maleficence: The principle of non-prejudice emphasizes "do no harm." For antibiotics, this means taking precautions to ensure that as few people as possible are harmed (Ancillotti et al., 2018). This principle motivates an ethical investigation of whether the long- term harm from antibiotic resistance outweighs the short-term harm from prophylactic antibiotic use Autonomy: Regarding treatment, respecting a patient's right to make an educated decision is essential. This principle is fundamental to antibiotic use, as patients must be adequately informed of the potential risks and benefits of prophylactic antibiotic therapy and their right to express informed consent (Appelbaum & Grisso, 2019). Justice:

Maintaining fairness and equity in healthcare decision-making is central to justice considerations. It raises issues about how the benefits and burden of antibiotic use are distributed across patient populations and communities. Beneficence: Population health professionals and physicians have an ethical obligation to put the best interests of their patients and the general public first. We must consider the advantages and disadvantages of using prophylactic antibiotics in high-risk settings to establish what is best for the health of communities and individual patients. Ethical Frameworks and Principles: 1. Beneficence: The duty to prioritize the welfare of patients and the community at large is central to the concept of beneficence. By lowering the imminent danger of life- threatening infections in at-risk patient populations like those undergoing surgery or those with impaired immune systems, prophylactic antibiotic usage in high-risk conditions is consistent with this notion (Pruitt, 2021). Preventing infections in these people is a morally laudable act in and of itself because it helps people live longer with less pain. 2. Balancing Autonomy: While the right to personal autonomy is undoubtedly important, it must be weighed against the principle of beneficence (Sullivan, 2019). Unfortunately, patients must fully understand the advantages and disadvantages of prophylactic antibiotics. Healthcare providers in these circumstances must make judgments that put the patient's health and safety first while also considering the patient's wishes to the greatest extent possible. Prophylactic antibiotics may be

a definite risk of infection by microorganisms present, In addition, there is a need for additional information about the risks associated with antibiotic use (Purba et al., 2018). Although there is a valid concern that antibiotic use may trigger autoimmune illnesses, this is not always the case. The rate at which antibiotics are used, the duration of treatment, and the prevalence of local infections are all factors in developing resistance. Risks can be minimized by carefully selecting antibiotics that are less likely to cause resistance and by carefully adhering to dosing and treatment length guidelines. . Ethical Analysis and Implications A careful examination of the ethical implications of authorizing prophylactic antibiotic use in high-risk scenarios reveals a nuanced set of competing principles and effects. Although the ethics of beneficence and utilitarianism allow for this activity to be legal, there are still some questions to be answered (Hodges-Mameletzis et al., 2018). The possible rise in antibiotic resistance is a primary ethical concern. When preventive antibiotics are permitted in high-risk scenarios, this practice may hasten the emergence of antibiotic-resistant strains, which has severe implications for public health. This conflict emerges from the competing priorities of ensuring the safety of antibiotics for the general population in the short term and those of surgical patients and those with impaired immune systems in the long run (Aslam et al., 2018). This moral conundrum highlights responsible antibiotic stewardship and decision-making based on evidence. Finding the sweet spot between short-term patient gains and long-term resistance threats calls for an all-encompassing strategy. Ethical practices must include

thoroughly monitoring usage, selecting products with a lower resistance potential, and strict adherence to dose and duration standards (Tarrant et al., 2019). Public health experts and policymakers must traverse these ethical difficulties, realizing that the decisions taken in this environment are not without trade-offs. To lessen the ethical repercussions, practitioners can take a nuanced and evidence-based approach to prophylactic antibiotic usage, maintaining patient and public health while preserving antibiotic efficacy for future generations. Arguments Against Prophylactic Antibiotic Use The possibility of escalating antibiotic resistance and its long-term effects on public health are among the concerns raised by those who oppose the use of antibiotics prophylactically. They emphasize the following points: 1. Threat from Antibiotic Resistance: The emergence and spread of ARB seriously jeopardizes the effectiveness of infection treatment. Globally, ARB infections are thought to have contributed to around 1.3 million deaths in 2019, and by 2050, this number is expected to increase to 10 million deaths (Antimicrobial Resistance Collaborators, 2022). 2. Improper Use: One of the main causes of the emergence and spread of ARB is the extensive use of antibiotics, frequently for unneeded or improper purposes. Prophylactic use increases the total pool of antibiotics utilized, especially in high-risk situations, which increases the selective pressure for ARB to arise and proliferate. 3. Effects Over Time: Antibiotic resistance may have disastrous effects over time. It might result in a reversion to the pre-antibiotic era when even common diseases could become fatal.

References Abumere, F. A. (2019). Utilitarianism. Introduction To Philosophy: Ethics . Albernaz-Gonçalves, R., Olmos, G., & Hötzel, M. J. (2021). Exploring Farmers’ Reasons for Antibiotic Use and Misuse in Pig Farms in Brazil. Antibiotics , 10 (3), 331. Ancillotti, M., Eriksson, S., Veldwijk, J., Nihlén Fahlquist, J., Andersson, D. I., & Godskesen, T. (2018). Public Awareness and Individual Responsibility Needed for Judicious Use of Antibiotics: A Qualitative Study of Public Beliefs and Perceptions. BMC Public Health , 18 , 1-9. Appelbaum, P. S., & Grisso, T. (2019). The Macarthur Treatment Competence Study. I: Mental Illness and Competence to Consent to Treatment1. Clinical Forensic Psychology and Law , 129-156. Ariza‐Heredia, E. J., & Chemaly, R. F. (2018). Update On Infection Control Practices in Cancer Hospitals. CA: A Cancer Journal for Clinicians , 68 (5), 340-355. Aslam, B., Wang, W., Arshad, M. I., Khurshid, M., Muzammil, S., Rasool, M. H., ... & Baloch, Z. (2018). Antibiotic Resistance: A Rundown of a Global Crisis. Infection And Drug Resistance , 1645–1658. Aslam, B., Wang, W., Arshad, M. I., Khurshid, M., Muzammil, S., Rasool, M. H., ... & Baloch, Z. (2018). Antibiotic Resistance: A Rundown of a Global Crisis. Infection And Drug Resistance , 1645–1658. Bauman, Z., & Haugaard, M. (2008). Liquid modernity and power: A dialogue with Zygmunt Bauman. Journal of Power , 1 (2), 111-130. Brock, D. W. (2018). Ethical Issues in The Use of Cost-Effectiveness Analysis for The Prioritisation of Health Care Resources. In The Ethics of Public Health, Volumes I And II (Pp. 441–463). Routledge. Dawson, L., Strathdee, S. A., London, A. J., Lancaster, K. E., Klitzman, R., Hoffman, I., ... & Sugarman, J. (2018). Addressing Ethical Challenges in HIV Prevention Research with People Who Inject Drugs. Journal Of Medical Ethics , 44 (3), 149–158. De Leeuw, E. (2017). Engagement of sectors other than health in integrated health governance, policy, and action. Annual Review of Public Health, pp. 38 , 329–349. Deng, H., King, I., & Lyu, M. R. (2008, December). Formal models for expert finding on dblp bibliography data. In 2008 Eighth IEEE International Conference on Data Mining (pp. 163-172). IEEE. Fernandez, M. E., Ruiter, R. A., Markham, C. M., & Kok, G. (2019). Intervention mapping: theory-and evidence-based health promotion program planning: perspective and examples. Frontiers in public health , 209. Grobler, G. M. (2019). To Serve Two Masters? A Moral Analysis of An Apparent Conflict of Interest In The Profession Of Occupational Physicians (Doctoral et al.: Stellenbosch University).

Harland, D. (2020). Infection Control: Understanding Diseases, Epidemiology, And Pathogen Transmission. Hodges-Mameletzis, I., Dalal, S., Msimanga-Radebe, B., Rodolph, M., & Baggaley, R. (2018). Going Global: The Adoption of The World Health Organization’s Enabling Recommendation on Oral Pre-Exposure Prophylaxis For HIV. Sexual Health , 15 (6), 489-500. Ikechukwu Anthony, K. A. N. U., & Ndubisi, E. J. (2022). Utilitarian Ethical Theory Vis- À-Vis the Contemporary Society: An Evaluation. Journal Of African Studies and Sustainable Development . Jackson, K. T. (2018). Interpreting The Virtues of Mindfulness and Compassion: Contemplative Practices and Virtue-Oriented Business Ethics. Humanistic Management Journal , 3 (1), 47–69. Kakkar, A. K., Shafiq, N., Singh, G., Ray, P., Gautam, V., Agarwal, R., ... & Arora, P. (2020). Antimicrobial Stewardship Programs in Resource-Constrained Environments: Understanding and Addressing the Need of The Systems. Frontiers In Public Health , 8 , 140. Kasirzadeh, A. (2021). Reasons, Values, Stakeholders: A Philosophical Framework for Explainable Artificial Intelligence. Arxiv Preprint Arxiv:2103.00752 . Keely Boyle, K., Rachala, S., & Nodzo, S. R. (2018). Centers For Disease Control and Prevention 2017 Guidelines for Prevention of Surgical Site Infections: Review and Relevant Recommendations. Current Reviews in Musculoskeletal Medicine , pp. 11 , 357–369. Keleher, H. E., MacDougall, C. E., & Murphy, B. E. (2007). Understanding health promotion . Oxford University Press. Li, B., & Webster, T. J. (2018). Bacteria Antibiotic Resistance: New Challenges and Opportunities for Implant‐Associated Orthopedic Infections. Journal Of Orthopaedic Research® , 36 (1), 22–32. Mahler, H. (2008). Public health advocacy and activism. Address to the 61st World Health Assembly. Mancuso, G., Midiri, A., Gerace, E., & Biondo, C. (2021). Bacterial Antibiotic Resistance: The Most Critical Pathogens. Pathogens , 10 (10), 1310. Mann, A., Nehra, K., Rana, J. S., & Dahiya, T. (2021). Antibiotic Resistance in Agriculture: Perspectives on Upcoming Strategies to Overcome Upsurge in Resistance. Current Research in Microbial Sciences , 2 , 100030. Murray, M. (2000). Social capital formation and healthy communities: Insights from the Colorado Healthy Communities Initiative. Community Development Journal, 35 (2), 99–108. Retrieved from https://www.jstor.org/stable/44257534 Podolsky, S. H. (2018). The Evolving Response to Antibiotic Resistance (1945– 2018). Palgrave Communications , 4 (1). Pruitt, A. A. (2021). Central Nervous System Infections in Immunocompromised Patients. Current Neurology and Neuroscience Reports , 21 (7), 37. Purba, A. K., Setiawan, D., Bathoorn, E., Postma, M. J., Dik, J. W. H., & Friedrich, A. W. (2018). Prevention Of Surgical Site Infections: A Systematic Review of Cost Analyses in Prophylactic Antibiotics. Frontiers In Pharmacology , 9 , 776.